Gastrointestinal Drugs Investment Global Outlook 2020
The global gastrointestinal drugs market is expected to decline from $40.2 billion in 2019 to $37.9 billion in 2020 at a CAGR of -5.75%, this is due to disruption in supply chains and restrictions on trade of pharmaceutical ingredients and products across countries owing to the COVID-19 outbreak.. The market is then expected to recover and grow at a CAGR of -1.35% from 2020 to reach $36.4 billion in 2023.
Gastrointestinal Drugs Investment Global Outlook 2020 provides strategists, marketers and senior management with the critical information they need to assess the global gastrointestinal drugs sector.
Reasons to Purchase
- Fully updated for 2020 including the impact of the Covid 19/ Novel Coronavirus.
- Identify growth segments and opportunities.
- Facilitate decision making on the basis of historic and forecast data and key trends
- Develop strategies based on likely future developments.
- Gain a global perspective on the development of the market.
Gastrointestinal Drugs Investment Global Outlook 2020 from the Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, trends and strategies for this market.
The market characteristics section of the report defines and explains the market.
The market size section gives the gastrointestinal drugs market revenues, covering both the historic growth of the market and forecasting the future.
Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.
The trends and strategies section highlights the likely future developments in the gastrointestinal drugs market and suggests approaches.
Markets Covered: Antiulcerants; Vitamin And Minerals; Antacids; Antiemetics And Antinauseants; Antiobesity; Antidiarrhoeals
Geographic scope: Asia Pacific, North America, Western Europe, Eastern Europe, South America, Middle East, Africa
Countries: Australia, China, Hong Kong, India, Indonesia, Japan, South Korea, Malaysia, New Zealand, Philippines, Singapore, Thailand, Vietnam, Canada, USA, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela, Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, the UK, Czech Republic, Poland, Romania, Russia, Israel, Saudi Arabia, Turkey, UAE, Egypt, Nigeria, South Africa
Time series: Five years historic and forecast
Data: Market value in $ billions.
Data segmentations: Regional breakdowns, key sub segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.